Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CHCHD2P3 is a pseudogene in the human genome, representing a retrocopy of the protein-coding gene CHCHD2. Like other processed pseudogenes, it does not encode a functional protein but reflects evolutionary gene duplication and mutation. Pseudogenes, in general, may have regulatory RNA roles, such as acting as competing endogenous RNAs (ceRNAs) or producing small RNAs, although this is rare and context-dependent. There is currently no evidence for a specific function, disease association, or pharmacological relevance of CHCHD2P3 itself.
There are no drugs targeting CHCHD2P3, so no mechanism of action applies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil-helix-coiled-coil-helix domain containing 2 pseudogene 3 (CHCHD2P3).